First Citizens Bank & Trust CO Charles River Laboratories International, Inc. Transaction History

First Citizens Bank & Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$204.13 - $302.4 $301,704 - $446,947	-1,478 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$255.51 - $362.11 $45,480 - $64,455	-178 Reduced 10.75%	1,478 $420,000
Q4 2021 Mar 11, 2022	BUY	$351.38 - $448.68 $6,324 - $8,076	18 Added 1.1%	1,656 $624,000
Q3 2021 Oct 15, 2021	BUY	$372.64 - $458.3 $71,919 - $88,451	193 Added 13.36%	1,638 $676,000
Q2 2021 Jul 14, 2021	BUY	$294.17 - $371.65 $425,075 - $537,034	1,445 New	1,445 $535,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on First Citizens Bank & Trust CO with notifications on news.